Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Aneurysm & intracranial embolization · Massachusetts | Aneurysm & intracranial embolization · New York | |
|---|---|---|
| Surgeons, 2024 | 13 | 25 |
| Medicare fee-for-service cases | 456 | 1,148 |
| Growth since 2019 (Medicare FFS) | +8%/yr | +12%/yr |
| Forecast cases (Medicare FFS) | 820 in 2030 | 1,980 in 2030 |
| Forecast growth | +10%/yr to 2030 | +9.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.5 | 0.6 |
| Medicare Advantage share | 39% | 57% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 35 | 46 |
| Top 10 surgeons' share | 89% | 61% |
| Surgeons growing | 2 | 5 |
| New since the base year | 3 | 7 |
| Likely to stop billing it | 3 by 2026 | 4 by 2026 |
| Forecast miss, 1 year (procedure) | 13% | 13% |
| Company payments per surgeon | $20K | $41K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.